Recently added

Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)

P. Nyssen, Olga; Vaira, Dino; saracino, ilaria maria; Fiorini, Giulia; Caldas, María; Bujanda, Luis; OBLITAS SUSANIBAR, ELIDA (MDPI, 2022-03-16)

Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled Trial

Ortega, Ana Laura; Coves-Sarto, Juan; Calvo, Virginia; MARSÉ FABREGAT, RAQUEL; provencio, mariano; Dómine, M; Blanco, Remei (American Medical Association, 2023-03-01)

Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study

Buonsenso, Danilo; Perramon, Aida; Català, Martí; Torres, Juan P; Camacho, Germán; Rojas-Solano, Mariela; MARTINEZ-MEJIAS, ABEL (Lippincott, Williams & Wilkins, 2022-12-01)

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab

Baston Rey, Iria; Fernández-Salgado, Estela; González García, Javier; Ramos, Laura; Diz-Lois Palomares, Mª Teresa; Monfort, David; Chaparro, María (MDPI, 2022-08-03)

Prognosis of acute heart failure based on clinical data of congestion

Espinosa, B.; Llorens, P.; Gil, V.; Rossello, Xavier; Jacob, J.; Herrero-Espilez, Pilar; Tost, Josep; Berenguer-Poblet, Marta; Donea, R. (Elsevier, 2022-07)

Scientia. Department of Health Digital Information Depot

CST - Articles científics: Recent submissions

Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)

Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled Trial

Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab

Prognosis of acute heart failure based on clinical data of congestion

Scientia. Department of Health Digital Information Depot

CST - Articles científics: Recent submissions

Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) ﻿

Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled Trial ﻿

Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study ﻿

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab ﻿

Prognosis of acute heart failure based on clinical data of congestion ﻿

Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)

Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled Trial

Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab

Prognosis of acute heart failure based on clinical data of congestion